Advent and Great Hill completed the investment in RxBenefits at a $1.1bn valuation.

Private equity firms Advent International and Great Hill Partners completed the investment in RxBenefits, a provider of pharmacy plans, expert advice, superior service, and guaranteed rates, at a $1.1bn valuation. "RxBenefits is the industry’s only fully independent, client-aligned, multi-PBM platform delivering tangible pharmacy savings, optimized clinical outcomes and a superior customer experience. Advent brings a robust track record in the healthcare services and tech sectors, and their investment is a testament to the opportunities ahead. We look forward to growing in partnership with Advent and Great Hill as we continue to build out our specialty and clinical programs to deliver additional cost savings to our clients," Bryan Statham, RxBenefits CEO.